266 related articles for article (PubMed ID: 22435959)
1. Recognizing pitfalls in virtual screening: a critical review.
Scior T; Bender A; Tresadern G; Medina-Franco JL; Martínez-Mayorga K; Langer T; Cuanalo-Contreras K; Agrafiotis DK
J Chem Inf Model; 2012 Apr; 52(4):867-81. PubMed ID: 22435959
[TBL] [Abstract][Full Text] [Related]
2. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
[TBL] [Abstract][Full Text] [Related]
3. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
[TBL] [Abstract][Full Text] [Related]
4. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
[TBL] [Abstract][Full Text] [Related]
5. Beware of machine learning-based scoring functions-on the danger of developing black boxes.
Gabel J; Desaphy J; Rognan D
J Chem Inf Model; 2014 Oct; 54(10):2807-15. PubMed ID: 25207678
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics-based virtual screening: accelerating the drug discovery process by high-performance computing.
Ge H; Wang Y; Li C; Chen N; Xie Y; Xu M; He Y; Gu X; Wu R; Gu Q; Zeng L; Xu J
J Chem Inf Model; 2013 Oct; 53(10):2757-64. PubMed ID: 24001302
[TBL] [Abstract][Full Text] [Related]
8. Identification of new Fyn kinase inhibitors using a FLAP-based approach.
Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A
J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328
[TBL] [Abstract][Full Text] [Related]
9. How far can virtual screening take us in drug discovery?
Kar S; Roy K
Expert Opin Drug Discov; 2013 Mar; 8(3):245-61. PubMed ID: 23330660
[TBL] [Abstract][Full Text] [Related]
10. Ligand aligning method for molecular docking: alignment of property-weighted vectors.
Joung JY; Nam KY; Cho KH; No KT
J Chem Inf Model; 2012 Apr; 52(4):984-95. PubMed ID: 22471323
[TBL] [Abstract][Full Text] [Related]
11. Charting a Path to Success in Virtual Screening.
Forli S
Molecules; 2015 Oct; 20(10):18732-58. PubMed ID: 26501243
[TBL] [Abstract][Full Text] [Related]
12. Structure-based virtual screening for novel ligands.
Pitt WR; Calmiano MD; Kroeplien B; Taylor RD; Turner JP; King MA
Methods Mol Biol; 2013; 1008():501-19. PubMed ID: 23729265
[TBL] [Abstract][Full Text] [Related]
13. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
Kurczab R; Bojarski AJ
J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening data fusion using both structure- and ligand-based methods.
Svensson F; Karlén A; Sköld C
J Chem Inf Model; 2012 Jan; 52(1):225-32. PubMed ID: 22148635
[TBL] [Abstract][Full Text] [Related]
15. Structure-based computational approaches for small-molecule modulation of protein-protein interactions.
Xu D; Wang B; Meroueh SO
Methods Mol Biol; 2015; 1278():77-92. PubMed ID: 25859944
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous classifier fusion for ligand-based virtual screening: or, how decision making by committee can be a good thing.
Riniker S; Fechner N; Landrum GA
J Chem Inf Model; 2013 Nov; 53(11):2829-36. PubMed ID: 24171408
[TBL] [Abstract][Full Text] [Related]
17. An integrated virtual screening approach for VEGFR-2 inhibitors.
Zhang Y; Yang S; Jiao Y; Liu H; Yuan H; Lu S; Ran T; Yao S; Ke Z; Xu J; Xiong X; Chen Y; Lu T
J Chem Inf Model; 2013 Dec; 53(12):3163-77. PubMed ID: 24266594
[TBL] [Abstract][Full Text] [Related]
18. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
19. Importance of the pharmacological profile of the bound ligand in enrichment on nuclear receptors: toward the use of experimentally validated decoy ligands.
Lagarde N; Zagury JF; Montes M
J Chem Inf Model; 2014 Oct; 54(10):2915-44. PubMed ID: 25250508
[TBL] [Abstract][Full Text] [Related]
20. Molecular fields in ligand discovery.
Gane PJ; Chan AW
Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]